Servotronics, Inc. (NYSEAMERICAN:SVT) Insider James C. Takacs Sells 3,500 Shares of Stock

Servotronics, Inc. (NYSEAMERICAN:SVT) insider James C. Takacs sold 3,500 shares of the company’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $12.55, for a total transaction of $43,925.00. Following the completion of the transaction, the insider now owns 13,113 shares of the company’s stock, valued at approximately $164,568.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Servotronics Stock Up 2.0 %

Servotronics stock opened at $12.60 on Friday. The stock has a market capitalization of $32.26 million, a PE ratio of -3.21 and a beta of 0.56. Servotronics, Inc. has a fifty-two week low of $8.80 and a fifty-two week high of $14.10.

Institutional Investors Weigh In On Servotronics

A hedge fund recently raised its stake in Servotronics stock. Oppenheimer & Close LLC increased its stake in shares of Servotronics, Inc. (NYSEAMERICAN:SVT) by 7.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 108,094 shares of the conglomerate’s stock after buying an additional 7,367 shares during the quarter. Servotronics comprises about 1.3% of Oppenheimer & Close LLC’s holdings, making the stock its 26th largest position. Oppenheimer & Close LLC owned approximately 4.24% of Servotronics worth $1,486,000 as of its most recent filing with the Securities & Exchange Commission. 24.77% of the stock is owned by institutional investors.

About Servotronics

Servotronics, Inc designs, manufactures, and markets servo-control components and other technology products for aerospace, military, and medical applications in the United States and internationally. It offers high-performance servo valves, including torque motor, hydraulic, and pneumatic valves. The company offers its products to products are sold to commercial aerospace, government, medical, and industrial markets.